Last reviewed · How we verify

NCT02791633: REmLap

Recovery After Emergency Laparotomy: a Prospective Observational Feasibility Study

Completed Last updated 28 March 2022
What this trial tests

trial testing Questionnaire in Quality of Life in 75 participants. Completed in 31 January 2022.

Timeline
10 July 2017
Primary endpoint
28 February 2020
31 January 2022

Quick facts

Lead sponsorDudley Group NHS Foundation Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment75
Start date10 July 2017
Primary completion28 February 2020
Estimated completion31 January 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Dudley Group NHS Foundation Trust

Who can join

18 and older, any sex, with Quality of Life or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational feasibility study using Patient Reported Outcomes (PRO) to assess quality of life and 'return to normal life' up to 1 year following emergency laparotomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02791633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing